Repotin (recombinant human erythropoietin biosimilar) / Genius Biotherapeutics - LARVOL DELTA

Integrating Advanced Metabolomics and Machine Learning for Anti-Doping in Human Athletes. (PubMed, Metabolites) - "Case studies illustrate the value of integrating metabolomics and ML-for example, detecting recombinant human erythropoietin (r-HuEPO) use via indirect blood markers and uncovering testosterone and corticosteroid abuse with extended detection windows. Future progress will rely on interdisciplinary collaboration, open-access data infrastructure, and continuous methodological innovation to fully realize the complementary role of these technologies in supporting fair play and athlete well-being."

Journal • Review

Post-test genetic repoting: clinical genetics best practices (ISTH 2025) - No abstract available

Clinical • Cardiovascular • Hematological Disorders • Thrombosis

High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns. (PubMed, J Pediatr) - "In extremely low gestational age newborns, r-HuEPO therapy promoted erythropoiesis. Despite a biomarker-based standardized high-dose iron supplementation, the majority of infants had evidence of iron deficiency to a degree that is associated with reduced brain function."

Journal • EPO